Literature DB >> 29696520

ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-authors' reply.

Emanuel Raschi1, Igor Diemberger2, Benilde Cosmi3, Fabrizio De Ponti4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29696520     DOI： 10.1007/s11739-018-1853-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  5 in total

1.  ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations.

Authors:  Emanuel Raschi; Igor Diemberger; Benilde Cosmi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2017-09-23       Impact factor: 3.397

2.  ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations-comment.

Authors:  Leonardo Campiotti; Matteo Basilio Sutter; Elena Bolzacchini; Alessandro Squizzato
Journal:  Intern Emerg Med       Date:  2018-03-27       Impact factor: 3.397

Review 3.  Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis.

Authors:  Chatree Chai-Adisaksopha; Wilson Lam; Christopher Hillis
Journal:  Leuk Lymphoma       Date:  2015-10-20

Review 4.  Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.

Authors:  Yi Ling Teo; Han Kiat Ho; Alexandre Chan
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

5.  Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.

Authors:  Jonathan Douxfils; Hélène Haguet; François Mullier; Christian Chatelain; Carlos Graux; Jean-Michel Dogné
Journal:  JAMA Oncol       Date:  2016-05-01       Impact factor: 31.777
  5 in total
  3 in total

Review 1.  Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs.

Authors:  Panagiota Papazoglou; Luying Peng; Agapios Sachinidis
Journal:  Front Cardiovasc Med       Date:  2021-04-27

2.  Subclinical Arteriosclerosis is Associated With Common Vascular Risk Factors in Long-Term Survivors of Testicular Cancer.

Authors:  Javier Espíldora-Hernández; Tania Díaz-Antonio; Javier Baena-Espinar; Inmaculada Alonso-Calderón; José Rioja; Emilio Alba-Conejo; Pedro Valdivielso; Miguel-Ángel Sánchez-Chaparro
Journal:  J Clin Med       Date:  2020-03-31       Impact factor: 4.241

Review 3.  The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia.

Authors:  Milo Gatti; Emanuel Raschi; Elisabetta Poluzzi; Cristian Martignani; Stefania Salvagni; Andrea Ardizzoni; Igor Diemberger
Journal:  Curr Heart Fail Rep       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.